FocaL Mass Drug Administration for Vivax Malaria Elimination — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

FocaL Mass Drug Administration for Vivax Malaria Elimination — Stella

Home/Plasmodium Vivax Malaria/

View on ClinicalTrials.gov

Recruiting

Back to Plasmodium Vivax Malaria trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Peru

Asociación Civil Selva Amazónica, Iquitos

Key details

Phase

Large-scale testing

Sponsor

University of California, San Francisco

Collaborators

Universidad Peruana Cayetano Heredia- subcontractor to UCSF as local Sponsor, PATH

Enrollment target

~7,530 participants

Started

October 2024

Primary completion

May 2027

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.